II. Epidemiology
- Immunocompetent patients (asymptomatic) Prevalence
- United States: 60 Million (11% of U.S. population over age 6 years old)
- Adolescents: 23% have Toxoplasmosis antibodies
- Young women: 15%
- Congenital Toxoplasmosis (Intrapartum exposure)
- Cases in U.S. per year: 400 to 4000
- HIV Patients
- Most common cause of cerebral mass lesions in HIV
III. Pathophysiology
- Intracellular coccidian Protozoan
- Main host: Feidae family including domestic cats
- Small rodents become infected by ingesting oocysts
- Outdoor cats become infected by eating small rodents
- Cats pass oocysts in feces during acute infection
- Oocysts sporulate (infectious) in environment
- Oocysts infectious for >1 year in warm, moist soil
- Indoor cats not fed raw meat unlikely to be infected
- Serologic Testing of cats is not useful
- Stages of life cycle
- Tachyzoite (invade cells and replicate)
- Bradyzoite (dormant as tissue cysts)
- Sporozoite (oocysts in environment)
- Sites of infection (most common)
- Trasmission
- Raw or under-cooked meat (pork, lamb, deer, cattle, sheep, goats)
- May also me transmitted by contaminated utensils and cutting boards
- Responsible for 50% of cases in U.S.
- Vertical Transmission across placenta (intrapartum, congenital infection)
- Toxoplasmosis infection before conception
- Rare transmission unless Immunocompromised
- First trimester infection: 10-25% transmission
- Third trimester infection: 60-90% transmission
- Toxoplasmosis infection before conception
- Ingesting items contaminated with infected cat feces
- Incubation to infectious state requires >1 day
- Cats shed for weeks when newly infected
- Litter box exposure
- Gardening soil
- Unfiltered water
- Unwashed vegetables or fruits
- Incubation to infectious state requires >1 day
- Blood-borne pathogen
- Raw or under-cooked meat (pork, lamb, deer, cattle, sheep, goats)
- Incubation
- Under-cooked meat ingestion: 10-23 days
- Infected cat feces ingestion: 5-20 days
- Reactivation
- Organism stays remains inactive after infection until immunosupression
- Occurs only in immunosuppressed groups (e.g. HIV)
- CNS Infection is the most common site of reactivation
- HIV patients
IV. Presentation
- Immunocompetent patients
- Usually asymptomatic
- Generalized symptoms may be briefly present for 1-2 weeks (mild flu-like symptoms)
- Fever
- Malaise
- Myalgias
- Lymphadenopathy (cervical or occipital)
- Congenital Toxoplasmosis
- Often asymptomatic at birth
- Classic triad
- Chorioretinitis
- Hydrocephalus
- Intracranial calcifications
- General signs
- Jaundice
- Hepatosplenomegaly
- Lymphadenopathy
- Fever
- Anemia and Thrombocytopenia
- Ocular changes occur in 20-80% of cases (but may not minifest until adulthood)
- Chorioretinitis presents with Blurred Vision, Eye Pain, photophobia
- HIV patients (or otherwise immunosuppressed)
- Common
- Encephalitis (most common)
- Pneumonia
- Chorioretinitis
- Disseminated disease
- General Signs
- Fever
- Headache
- Seizure
- Cognitive Impairment is frequent presenting symptom
- Altered Mental Status (confusion)
- Altered behavior
- Focal neurologic deficit (60%)
- Hemiparesis
- Aphasia
- Ataxia or other altered coordination
- Visual Field Defects
- Cranial Nerve palsies
- Tremor
- Common
V. Labs: Screening
- Indications
- HIV Infection or other Immunosuppression
- Pregnant women with suspected exposure
- Routine screening in pregnancy not recommended
- Diagnostic Tests (protocol for age over 1 year)
- Step 1: Serum IgG Toxoplasmosis antibodies (97%)
- If positive, go to Step 2
- Stop if IgG negative
- Positive within 1-2 weeks of infection
- Consider retest in 3 weeks if negative, equivocal
- Step 2: Serum IgM Toxoplasmosis antibodies
- If positive, go to Step 3
- May be positive up to 18 months after infection
- Confirm positive test with a reference lab
- Checks for False Positives
- If negative, infection occurred >6 months ago
- If positive, go to Step 3
- Step 3: Serum IgG Toxoplasmosis avidity status
- If low, go to Step 4
- If high, infected 12 weeks or longer ago
- Step 4: Resend IgG, IgM and avidity after 3 weeks
- Go back to Step 1 to interpret findings
- If still not diagnostic, go to Step 5
- Step 5: Advanced testing
- Toxoplasmosis PCR
- Toxoplasmosis differential Agglutination
- Serum Toxoplasmosis IgA
- Serum Toxoplasmosis IgE
- Step 1: Serum IgG Toxoplasmosis antibodies (97%)
VI. Labs: Other Testing
- Fetal testing (Congenital Toxoplasmosis)
- Amniocentesis for Toxoplasmosis PCR
- Risk of False Positive and False Negative tests
- May be performed as early as 18 weeks gestation
- Immunosuppressed Patients in whom Immunoglobulin testing may be unreliable
- Toxoplasmosis PCR
- Microscopy of blood, tissue biopsy or cerebrospinal fluid
- HIV patients with mass lesion
- Brain biopsy (confirms the diagnosis)
- False Negatives may occur
VII. Imaging: HIV patients (Head CT scan or Head MRI)
- Brain MRI is more sensitive
- Ring enhancing lesions on CT with contrast
- Multiple bilateral lesions
- Basal Ganglia
- Corticomedullary junction
VIII. Management: Pregnancy
- Active Toxoplasmosis infection in pregnancy
- Infection in first or second trimester
- Spiramycin (Rovamycine)
- Most effective if started within 8 weeks of seroconversion
- Continue through remainder of pregnancy if no fetal infection
- Spiramycin (Rovamycine)
- Infection in Third Trimester (or late second trimester)
- See triple protocol for fetal Toxoplasmosis as below
- Infection in first or second trimester
- Fetal Toxoplasmosis confirmed by Amniocentesis (or third trimester infection)
- General
- Use not recommended before 13-18 weeks
- Also indicated in third trimester maternal infection (without known fetal infection)
- Protocol
- Pyrimethamine (Daraprim) and
- Sulfadiazine and
- Folinic acid (leucovorin)
- Prevents marrow suppression of Pyrimethamine
- General
IX. Management: Congenital Toxoplasmosis
- Treatment administered for 1 year
- Additional management needed for ocular infection
- Protocol
- Pyrimethamine (Daraprim) and
- Sulfadiazine and
- Folinic acid (leucovorin)
X. Management: HIV
- Most treatment started empirically
- Regimen (90% response rate in 1-2 weeks)
- Pyrimethamine and
- Sulfadiazine (or Clindamycin or Atovaquone)
- Folinic acid (Leucovorin)
- Drugs
- Pyrimethamine
- Initial Treatment: 200 mg orally for first dose
- Next
- Weight >60 kg: 75 mg orally daily
- Weight <60 kg: 50 mg orally daily
- Sulfadiazine
- Treatment Dose: 1.5 g (1.0 g if wt <60 kg) orally every 6 hours
- Clindamycin
- Indication: allergy to Sulfadiazine
- Initial: 600 mg every 6 hours
- Folinic Acid (Leucovorin)
- Indication: Less Pyrimethamine marrow suppression
- Dose: 10-25 mg orally daily
- Atovaquone
- Dose: 1500 mg orally twice daily
- Pyrimethamine
- Other medications: Corticosteroids
- Indication: severe cerebral edema
- Adverse Reactions (common) to treatment
- Neutropenia
- Rash
- Fever
- Renal Impairment
- Course
- Continue treatment until symptoms and imaging normal
- Continue low dose maintenance for patients life
- Pyrimethamine and Sulfadiazine low dose daily
XI. Complications
- Congenital Toxoplasmosis (up to 80% of cases)
- Mental Retardation (may not be evident until school)
- Blindness
- Seizure Disorder
- HIV patients
XII. Prevention
-
General Measures
- Peel or carefully wash all fruits and vegetables
- Fully cook all meats (especially beef, lamb, game)
- Carefully wash all items for preparing food
- Wear gloves when handling soil (i.e. gardening)
- Pet cat care
- Patients at risk should not change cat litter
- Immunosuppressed patients (e.g. HIV)
- Pregnant patients
- Wear gloves when changing cat litter
- Wash hands carefully after changing litter box
- Change litter daily (before infectious)
- Keep cat inside and avoid strays
- Use only commercial or cooked cat food
- Patients at risk should not change cat litter
- HIV Patients: Toxoplasmosis Prophylaxis
- See Prevention of Secondary Infection in HIV
- Baseline toxoplasma Serology in all HIV patients
- Primary Prophylaxis is indicated if CD4 Count <100 cells/mm3 or if seropositive
- Trimethoprim-Sulfamethoxazole, Bactrim, or Septra DS daily (same as for Pneumocystis Prophylaxis) or
- Dapsone and Pyrimethamine has also been used
- Chronic Suppression (Secondary Prophylaxis, until CD4 Count >200 for 6 months)
- Sulfadiazine 2-4 g/day orally divided bid to qid (or Clindamycin 600 mg every 8 hours) AND
- Pyrethamine 25-50 mg orally every 24 hours AND
- Folinic Acid 10-25 mg orally every 24 hours